The US Pharmacopoeia (USP) will be ramping up its operations in India, according to KV Surendranath,The USP, a scientific non-profit organisation that sets standards for the identity, strength, quality, and purity of medicines, will be investing $200 million over next five years in consolidation of its operations.
While speaking to newspersons on the sidelines of a workshop for the Asia-Pacific chapter of the Network of Official Medicines Control Laboratories which began here on Tuesday, Surendranath said a part of this investment will also be spent in India.
The activities of the USP in India will increase including the work on medical monograph modernisation. “The future investment in India will mainly go into manpower, expansion of activities and technology,’’ he said.
Business Line
By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…
Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…
New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…
National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…
Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…
New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…